A high-performance nanobio photocatalyst for targeted brain cancer therapy

Nano Lett. 2009 Sep;9(9):3337-42. doi: 10.1021/nl901610f.

Abstract

We report pronounced and specific antiglioblastoma cell phototoxicity of 5 nm TiO(2) particles covalently tethered to an antibody via a dihydroxybenzene bivalent linker. The linker application enables absorption of a visible part of the solar spectrum by the nanobio hybrid. The phototoxicity is mediated by reactive oxygen species (ROS) that initiate programmed death of the cancer cell. Synchrotron X-ray fluorescence microscopy (XFM) was applied for direct visualization of the nanobioconjugate distribution through a single brain cancer cell at the submicrometer scale.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Antibodies, Monoclonal / pharmacology*
  • Antibodies, Monoclonal / therapeutic use
  • Brain Neoplasms / drug therapy*
  • Catalysis
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Drug Screening Assays, Antitumor
  • Humans
  • Hydroquinones / chemistry
  • Hydroquinones / pharmacology*
  • Materials Testing
  • Models, Biological
  • Nanoparticles / chemistry*
  • Nanotechnology
  • Particle Size
  • Photochemistry
  • Surface Properties
  • Titanium / chemistry
  • Titanium / pharmacology*

Substances

  • Antibodies, Monoclonal
  • Hydroquinones
  • titanium dioxide
  • Titanium